North America Breast Reconstruction Industry Overview
The North America breast reconstruction market size was valued at USD 206.10 million in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 6.69% from 2022 to 2030. Rising breast cancer patients and an increase in the number of breast reconstruction surgeries are the major factors driving the market. Moreover, the availability of reimbursement policies with respect to breast reconstruction is further boosting the North America breast reconstruction market.
The incidence rate of breast cancer has increased considerably in the past two decades. For instance, as per Cancer.net, from the mid-2000s, invasive breast cancer in women has increased approximately by half a percent every year. Moreover, as per a similar source, it is estimated that 287,850 women in the U.S. are expected to be diagnosed with invasive breast cancer in 2022.
Gather more insights about the market drivers, restrains and growth of the North America Breast Reconstruction market
Additionally, as per the Canadian Cancer Society, breast cancer is the most common cancer among Canadian women. For instance, according to a similar source, it is estimated that 27,700 Canadian women were expected to be diagnosed with breast cancer. Moreover, 13.0% of the women were expected to die from breast cancer. To minimize the risk of breast cancer, many women opt for mastectomy & lumpectomy procedures; as a result, the demand for breast reconstruction products is anticipated to increase throughout the forecast period.
The growing adoption of breast reconstruction procedures is another factor responsible to drive the North America breast reconstruction market. For instance, American Society of Plastic Surgeons, the overall breast reconstruction procedures were calculated to be 137,808in 2020, which is 75.0% more than the breast reconstruction surgeries, held in 2000. Thus, the growing demand for breast reconstruction procedures may boost the North America breast reconstruction market, during the forecast period.
Furthermore, Medicare usually does not cover most cosmetic surgeries. However, Medicare covers breast reconstruction only if the person has had a mastectomy due to breast cancer. According to Mentor Medical Systems B.V., the Medicare national average payment may vary from USD 147 to USD 10,623 depending upon the procedure.
Moreover, the national average payment also varies depending upon the place where the surgery takes place. For instance, the breast reconstruction by a physician is reimbursed at an average payment of USD 1,193, whereas, the similar is reimbursed at a payment of USD 14,929 and USD 5,635 at hospital outpatient and ambulatory surgical centers respectively. Therefore, the availability of suitable reimbursement policies is promoting breast reconstruction in women who had a mastectomy, which is expected to help the development of the North America breast reconstruction market during the forecast period.
The COVID-19 pandemic was anticipated to have a negative impact on the North America breast reconstruction market. This can be attributed to the termination & delay of elective treatments including breast reconstruction. However, as the cases of COVID-19 have reduced, and vaccination has started globally, elective surgery for breast reconstruction is expected to take place. This may push the market growth during the forecast period. Moreover, to cope with the demand, and have a larger patient reach, many companies adopted strategies such as raising awareness campaigns, partnerships, and product approvals.
Besides, some companies opted for clinical trials during the post-pandemic period, which was expected to boost the North America breast reconstruction market growth. For instance, in March 2021, Surgical Innovation Associates initiated a clinical trial under an Investigational Device Exemption from the U.S. FDA, which accessed the durability & effectiveness of their product Dura Sorb. This was expected to drive the company’s market growth.
Similarly, in October 2021, Sientra, Inc. and Mission Plasticos launched a nationwide Reshaping Lives: Full Circle program, to provide reconstructive breast surgery for women living in poverty. Thus, with such strategies initiated by the key players, the North America breast reconstruction market is projected to witness significant growth during the post-pandemic period.
Browse through Grand View Research's Healthcare IT Industry Research Reports.
- Hypertrophic And Keloid Scar Treatment Market - The global hypertrophic and keloid scar treatment market size was valued at USD 6.34 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 8.47% from 2022 to 2030.
- ECG Patch And Holter Monitor Market - The global ECG patch and holter monitor market was valued at USD 1.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 19.16% from 2022 to 2030.
North America Breast Reconstruction Market Segmentation
Grand View Research has segmented the North America breast reconstruction market report based on the product, shape, end-use, and region:
North America Breast Reconstruction Product Outlook (Revenue, USD Million, 2018 - 2030)
- Implants
- Silicone Breast Implants
- Saline Breast Implants
- Tissue Expander
- Saline Expander
- Air Tissue Expanders
- Acellular Dermal Matrix
North America Breast Reconstruction Shape Outlook (Revenue, USD Million, 2018 - 2030)
- Round Shape
- Anatomical Shape
North America Breast Reconstruction End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Cosmetology Clinics
- Ambulatory Surgical Centers
Market Share Insights
- December 2020: Motiva USA LLC received a CE mark for its next-generation Motive Ergonomicx2 silicone breast implant platform.
- July 2021: BD acquired Tepha, Inc. This helped BD to use Tepha’s patented resorbable polymer to expand their mesh portfolio’s innovation potential for soft tissue repair, reconstruction & regeneration segments.
Key Companies profiled:
Some of the key players in the North America breast reconstruction market include:
- Mentor Medical Systems B.V. (Johnson & Johnson)
- Abbvie (Allergan Inc.)
- Integra Life sciences Corporation
- Sientra, Inc.
- Ideal Implant Incorporated
- Stryker Corporation
- Establishment Labs Holding, Inc. (Motiva USA LLC)
- RTI Surgical
- MTF Biologics
- SIA (Surgical Innovation Associates)
- Tela Bio, Inc.
Order a free sample PDF of the North America Breast Reconstruction Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
